...
首页> 外文期刊>Molecular Therapy - Methods & Clinical Development >Original Article C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey
【24h】

Original Article C3 Transferase-Expressing scAAV2 Transduces Ocular Anterior Segment Tissues and Lowers Intraocular Pressure in Mouse and Monkey

机译:原制品C3转移酶表达SCAAV2转换眼前段组织,降低小鼠和猴子的眼压

获取原文

摘要

Glaucoma is a lifelong disease with elevated intraocular pressure (IOP) as the main risk factor, and reduction of IOP remains the major treatment for this disease. However, current IOP-lowering therapies are far from being satisfactory. We have demonstrated that the lentivirus-mediated exoenzyme C3 transferase (C3) expression in rat and monkey eyes induced relatively long-term IOP reduction. We now show that intracameral injection of self-complementary AAV2 containing a C3 gene into mouse and monkey eyes resulted in morphological changes in trabecular meshwork and IOP reduction. The vector-transduced corneal endothelium and the C3 transgene expression, not vector itself, induced corneal edema as a result of actin-associated endothelial barrier disruption. There was a positive (quadratic) correlation between measured IOP and grade of corneal edema. This is the first report of using an AAV to transduce the trabecular meshwork of monkeys with a gene capable of altering cellular structure and physiology, indicating a potential gene therapy for glaucoma.
机译:青光眼是一种终身疾病,具有升高的眼压(IOP)作为主要风险因素,并且IOP的减少仍然是这种疾病的主要治疗方法。然而,目前的IOP疗法远非令人满意。我们已经证明,在大鼠和猴眼中的慢病毒介导的外酶C3转移酶(C3)表达诱导相对长期的IOP减少。我们现在表明,肠道内注射含有C3基因的自互补AAV2进入小鼠和猴眼,导致胫胚组的形态变化和IOP减少。载体转导的角膜内皮和C3转基因表达,不是载体本身,由于肌动蛋白相关的内皮阻隔破坏而诱导角膜水肿。测量的IOP和角膜水肿等级之间存在阳性(二次)相关性。这是使用AAV通过能够改变细胞结构和生理学的基因来转移AAV的第一报告,该基因表明潜在的青光眼潜在基因治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号